Author

Francesco Graziano

A Propensity Score-Weighted Comparison of Vedolizumab, Adalimumab, and Golimumab in Patients with Ulcerative Colitis: Real-Life Data from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD)

Fabio Salvatore Macaluso, Marco Ventimiglia, Walter Fries, Maria Cappello, Barbara Scrivo, Antonio Magnano, Dario Pluchino, Salvatore Camilleri, Serena Garufi, Roberto Di Mitri, Filippo Mocciaro, Giovanni Magri, Concetta Ferracane, Michele Citrano, Francesco Graziano, Carmelo Bertolami, Sara Renna, Rosalba Orlando, Giulia

Item 1 - 1 / 1
1
We use cookies in order to provide you with a better browsing experience. This includes third-party cookies for traffic analyzation purposes. See here for more information.
OK